Jared Kelly
Chief Executive Officer, Oncolytics Biotech.
Companies
- Oncolytics BiotechBoard member Jan 2, 2026 to now1
- Oncolytics BiotechChief executive officer Jan 2, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Oncolytics Biotech ONCY114,050 shares2$57.3K at $0.50Mar 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 12, 2026Bought 5,050 shares at $0.96 of Oncolytics Biotech2
- Feb 12, 2026Bought 29,500 shares at $0.84 of Oncolytics Biotech3
- Feb 11, 2026Bought 5,600 shares at $0.84 of Oncolytics Biotech3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGAROncolytics Biotech, Board member
- 2
- 3SEC EDGARForm 4 filed Feb 13, 2026